BGLAP and postmenopausal osteoporosis: In the beginning of the treatment, serum OCN concentration had been higher in our OVX model than in non-OVX mice (Fig 1b), which is consistent with the known increase of this marker in postmenopausal osteoporosis due to an imbalance in bone turnover.